166 related articles for article (PubMed ID: 28482415)
21. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U
Nephron; 1992; 61(3):263-5. PubMed ID: 1323768
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya.
Elzouki AN; Bushala M; Tobji RS; Khfaifi M
Nephrol Dial Transplant; 1995; 10(4):475-6. PubMed ID: 7542751
[No Abstract] [Full Text] [Related]
23. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.
Toyoda H; Kumada T; Tada T; Takaguchi K; Ishikawa T; Tsuji K; Zeniya M; Iio E; Tanaka Y
J Gastroenterol; 2016 Jul; 51(7):741-7. PubMed ID: 26872889
[TBL] [Abstract][Full Text] [Related]
24. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
[TBL] [Abstract][Full Text] [Related]
26. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.
Constancio NS; Ferraz MLG; Martins CTB; Kraychete AC; Bitencourt PL; Nascimento MMD
J Bras Nefrol; 2019; 41(4):539-549. PubMed ID: 30806444
[TBL] [Abstract][Full Text] [Related]
28. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
29. HBV-DNA in hemodialysis patients infected by HCV.
Arababadi MK; Hassanshahi G; Yousefi H
Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941
[TBL] [Abstract][Full Text] [Related]
30. High incidence of hepatitis C virus antibodies in hemodialysis patients.
Machida J; Yamaguchi K; Ueda S; Yoshida M; Kusumoto Y; Nishimura Y; Futami G; Ishii T; Watanabe T; Takatsuki K
Nephron; 1992; 60(1):117-8. PubMed ID: 1310800
[No Abstract] [Full Text] [Related]
31. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
[TBL] [Abstract][Full Text] [Related]
32. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
[TBL] [Abstract][Full Text] [Related]
34. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study.
Abdelmoemen G; Khodeir SA; Abou-Saif S; Kobtan A; Abd-Elsalam S
Environ Sci Pollut Res Int; 2018 Feb; 25(6):5459-5464. PubMed ID: 29214477
[TBL] [Abstract][Full Text] [Related]
36. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
Batchoun RG; Al-Najdawi MA; Al-Taamary S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
[TBL] [Abstract][Full Text] [Related]
37. Acute hepatitis C in patients receiving hemodialysis.
Griveas I; Germanidis G; Visvardis G; Morice Y; Perelson AS; Pawlotsky JM; Papadopoulou D
Ren Fail; 2007; 29(6):731-6. PubMed ID: 17763169
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of hepatitis C virus infection and genotypes in patient with chronic kidney disease undergoing hemodialysis.
de Jesus Rodrigues de Freitas M; Fecury AA; de Almeida MK; Freitas AS; de Souza Guimarães V; da Silva AM; da Costa YF; da Costa RA; Ferreira P; Martins LC
J Med Virol; 2013 Oct; 85(10):1741-5. PubMed ID: 23852735
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
[TBL] [Abstract][Full Text] [Related]
40. [Viral hepatitis in hemodialysis and renal transplantation patients].
Pol S; Legendre C
Nephrologie; 1994; 15(3):191-5. PubMed ID: 7969710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
